Blood tests may predict cancer return after radiation
NCT ID NCT03325036
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study measured immune-related substances in the blood of 60 head and neck cancer patients before and after they received curative radiotherapy. The goal was to see if these markers could help predict whether the cancer would come back or spread. Researchers hope to find better ways to identify patients who need closer monitoring after treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors use blood tests to predict which patients are at higher risk of cancer returning after radiotherapy.
- What could go wrong
- This is a small, completed observational study, not a treatment trial. The findings may not lead to a widely used test or change patient care directly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCERS PATIENTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Taiwan University Hospital
Taipei, Taiwan